ConductScience.org, home

Paper7826293

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.

Arch Ophthalmol, 1995. Cited by 289 papers, by iCite.

Cite this record

ConductScience Library. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Papers, record 7826293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7826293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
PubMed
Journal
Arch Ophthalmol
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
289
iCite
Relative citation ratio, by iCite
8.48
iCite
Revised in PubMed
2019-07-04
PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Diabetic RetinopathyMajor topic
InsulinMajor topic
Adolescent
Adult
Blood Glucose
Disease Progression
Female
Follow-Up Studies
Humans
Incidence
Male
Risk Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00027287Laser and Medical Treatment of Diabetic Macular EdemaBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.

PMIDTitleJournalYearIn PapersSource
406314602025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.Diabetes Metab J2025https://conductscience.org/library/papers/40631460PubMed
390910052023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.Diabetes Metab J2024https://conductscience.org/library/papers/39091005PubMed
39063646Use of VESsel GENeration with Optical Coherence Tomography Angiography and Fluorescein Angiography for Detection and Quantification of Vascular Changes in Mild and Moderate Diabetic Retinopathy.Life (Basel)2024https://conductscience.org/library/papers/39063646PubMed
37896220Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus.Pharmaceutics2023https://conductscience.org/library/papers/37896220PubMed
37781457
ƩexcessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data.
Diabetol Int2023https://conductscience.org/library/papers/37781457PubMed
36824442Diabetic Macular Oedema Guidelines: An Australian Perspective.J Ophthalmol2023https://conductscience.org/library/papers/36824442PubMed
36815723Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36815723PubMed
36482340Nomogram model predicts the risk of visual impairment in diabetic retinopathy: a retrospective study.BMC Ophthalmol2022https://conductscience.org/library/papers/36482340PubMed
35896888Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology.Ophthalmol Ther2022https://conductscience.org/library/papers/35896888PubMed
35083418The effect of select systemic medications on outcomes in diabetics with central retinal vein occlusion.Ther Adv Ophthalmol2022https://conductscience.org/library/papers/35083418PubMed
35058313Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.BMJ Open Diabetes Res Care2022https://conductscience.org/library/papers/35058313PubMed
35052620Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study.Antioxidants (Basel)2022https://conductscience.org/library/papers/35052620PubMed
34861815A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy.Clin Proteomics2021https://conductscience.org/library/papers/34861815PubMed
343529842021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.Diabetes Metab J2021https://conductscience.org/library/papers/34352984PubMed
34234400Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control.Clin Ophthalmol2021https://conductscience.org/library/papers/34234400PubMed
34233927
Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.
Diabetes Care2021https://conductscience.org/library/papers/34233927PubMed
34081206Decision models in type 2 diabetes mellitus: A systematic review.Acta Diabetol2021https://conductscience.org/library/papers/34081206PubMed
33928529Sexual dysfunctions and short-term glucose variability in young men with type 1 diabetes.Hormones (Athens)2021https://conductscience.org/library/papers/33928529PubMed
33550441Realising the long-term promise of insulin therapy: the DCCT/EDIC study.Diabetologia2021https://conductscience.org/library/papers/33550441PubMed
33164750Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes.Elife2020https://conductscience.org/library/papers/33164750PubMed

See all 103 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7826293

GET https://conductscience.org/api/papers/v1/7826293/cited_by?page=2